<DOC>
	<DOC>NCT01821391</DOC>
	<brief_summary>This study will be conducted as a multi-centre, randomized, investigator-blind, active and vehicle-controlled, intra-individual study. The purpose of this study is to confirm that the Metvix NDL-PDT procedure is similar in efficacy and less painful when compared to Metvix c-PDT procedure for the treatment of mild and moderate AKs. In addition this study will include a Metvix NDL-PDT arm versus Metvix vehicle cream c PDT (Placebo) to assess the sensitivity of the trial.</brief_summary>
	<brief_title>Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Clinical diagnosis of mild (Grade 1) and/or moderate (Grade 2) AKs on the face or the scalp on treated areas Subject with two symmetrical treated areas half scalps or two half faces excluding ears, chin, bridge of the nose, eyelids and lips inside the vermillion border): no more than a twofold difference in terms of total number of lesions between the two TAs Subject with clinical diagnosis of at least one severe (Grade 3) AK on treated areas Subject with pigmented AK on the treated areas Immunocompromised Subject for idiopathic, disease specific or therapeutic reasons Subject with porphyria,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>actinic keratoses</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>natural daylight</keyword>
</DOC>